Browse Articles

Honey Bee Pollen in Allergic Rhinitis Healing

Bjelajac et al. | Jun 24, 2020

Honey Bee Pollen in Allergic Rhinitis Healing

The most common atopic disease of the upper respiratory tract is allergic rhinitis. It is defined as a chronic inflammatory condition of nasal mucosa due to the effects of one or more allergens and is usually a long-term problem. The purpose of our study was to test the efficiency of apitherapy in allergic rhinitis healing by the application of honey bee pollen. Apitherapy is a branch of alternative medicine that uses honey bee products. Honey bee pollen can act as an allergen and cause new allergy attacks for those who suffer from allergic rhinitis. Conversely, we hoped to prove that smaller ingestion of honey bee pollen on a daily basis would desensitize participants to pollen and thus reduce the severity of allergic rhinitis.

Read More...

Using Artificial Intelligence to Forecast Continuous Glucose Monitor(CGM) readings for Type One Diabetes

Jalla et al. | Aug 07, 2024

Using Artificial Intelligence to Forecast Continuous Glucose Monitor(CGM) readings for Type One Diabetes
Image credit: The authors

People with Type One diabetes often rely on Continuous Blood Glucose Monitors (CGMs) to track their blood glucose and manage their condition. Researchers are now working to help people with Type One diabetes more easily monitor their health by developing models that will future blood glucose levels based on CGM readings. Jalla and Ghanta tackle this issue by exploring the use of AI models to forecast blood glucose levels with CGM data.

Read More...

A novel approach for predicting Alzheimer’s disease using machine learning on DNA methylation in blood

Adami et al. | Sep 20, 2023

A novel approach for predicting Alzheimer’s disease using machine learning on DNA methylation in blood
Image credit: National Cancer Institute

Here, recognizing the difficulty associated with tracking the progression of dementia, the authors used machine learning models to predict between the presence of cognitive normalcy, mild cognitive impairment, and Alzheimer's Disease, based on blood DNA methylation levels, sex, and age. With four machine learning models and two dataset dimensionality reduction methods they achieved an accuracy of 53.33%.

Read More...

Investigating the effects of glucose reintroduction on acutely starved HeLa cells

Puduru et al. | Jul 05, 2026

Investigating the effects of glucose reintroduction on acutely starved HeLa cells

Cancer cells rely heavily on glycolysis, but how they respond when glucose is reintroduced after acute starvation is not well understood. Using fluorescence lifetime imaging microscopy, students tracked metabolic changes in HeLa cells and found a rapid shift toward glycolysis within 20 minutes of glucose reintroduction, followed by heterogeneous recovery toward oxidative phosphorylation. These results highlight metabolic flexibility and variability in cancer cells, offering insights relevant to treatment resistance and therapeutic design.

Read More...

SmartZoo: A Deep Learning Framework for an IoT Platform in Animal Care

Ji et al. | Aug 07, 2024

SmartZoo: A Deep Learning Framework for an IoT Platform in Animal Care

Zoos offer educational and scientific advantages but face high maintenance costs and challenges in animal care due to diverse species' habits. Challenges include tracking animals, detecting illnesses, and creating suitable habitats. We developed a deep learning framework called SmartZoo to address these issues and enable efficient animal monitoring, condition alerts, and data aggregation. We discovered that the data generated by our model is closer to real data than random data, and we were able to demonstrate that the model excels at generating data that resembles real-world data.

Read More...

Using explainable artificial intelligence to identify patient-specific breast cancer subtypes

Suresh et al. | Jan 12, 2024

Using explainable artificial intelligence to identify patient-specific breast cancer subtypes

Breast cancer is the most common cancer in women, with approximately 300,000 diagnosed with breast cancer in 2023. It ranks second in cancer-related deaths for women, after lung cancer with nearly 50,000 deaths. Scientists have identified important genetic mutations in genes like BRCA1 and BRCA2 that lead to the development of breast cancer, but previous studies were limited as they focused on specific populations. To overcome limitations, diverse populations and powerful statistical methods like genome-wide association studies and whole-genome sequencing are needed. Explainable artificial intelligence (XAI) can be used in oncology and breast cancer research to overcome these limitations of specificity as it can analyze datasets of diagnosed patients by providing interpretable explanations for identified patterns and predictions. This project aims to achieve technological and medicinal goals by using advanced algorithms to identify breast cancer subtypes for faster diagnoses. Multiple methods were utilized to develop an efficient algorithm. We hypothesized that an XAI approach would be best as it can assign scores to genes, specifically with a 90% success rate. To test that, we ran multiple trials utilizing XAI methods through the identification of class-specific and patient-specific key genes. We found that the study demonstrated a pipeline that combines multiple XAI techniques to identify potential biomarker genes for breast cancer with a 95% success rate.

Read More...